
Is dedicated to impactful businesses aiming to positively transform the world's food system.
- Cheque size
- $10K – $5M
- Stages
- Operating in
- How they invest
- Not specified
- Technologies
- Not specified

Is dedicated to impactful businesses aiming to positively transform the world's food system.
Ranked by shared stages, industries, geography, cheque size and investor type. 400 related investors in the directory.
Spearheaded by a former Google X founder, the firm brings a moonshot lab prototyping philosophy anchored in a structured Triad investment thesis encompassing deep technology, reimagined unit economics, and climate-positive outcomes. It stands out by offering hands-on prototyping assistance and reverse-engineering of unit-economics models for its portfolio.
Led by a solo GP, an early institutional investor that uses a learn-first networking approach—deep founder/category diligence—with bi-regional Columbus–Boulder presence centered on consumer, fashion, health/wellness, and brand+tech SaaS/IoT Through targeted capital deployment, the fund plays an active role in the startup ecosystem.
Seed-stage investor in dual-use deep tech (six verticals) with an invite-only U.S. Service Academy alumni syndicate that co-invests, sources, vets deals, presents post-investment support, and runs a veteran-led track. The firm continues to build its presence across the venture capital landscape.
Invests at the concept stage, co-founding and building breakthrough life sciences and deep-science platforms directly with university researchers, acting as a company-builder partner to commercialize frontier biology. With a disciplined investment approach, the team drives value for both founders and investors.
Bioscience investor translating grant-funded research into venture-scale companies, with a pipeline centered on engineering biology using robotic cloud labs and computational design for human health and planetary sustainability. Through targeted capital deployment, the fund plays an active role in the startup ecosystem.
Invests from napkin-stage through IPO using an evergreen own-capital model for patient, flexible long-term support; active nascent-stage investor (~180 deals) oriented toward deep bio and frontier software/crypto. With a disciplined investment approach, the team drives value for both founders and investors.